SELEPARINA

Medicinal product

(Invented) name

SELEPARINA

Active substance (s)

Nadroparino kalcio druska

Strength

2850 anti-Xa TV/0,3 ml

Pharmaceutical form

injekcinis tirpalas

Route (s) of administration

leisti į veną, leisti į arteriją, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

B01AB06, Nadroparin

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2025-12-12

Date of renewal

Documents

3078_3079_3080_Seleparina inj tirp_PZ_2025-12-12.docx

3078_3079_3080_Seleparina inj tirp_PL_2025-12-12.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

0,3 ml tirpalo yra:	0.3 ml
Nadroparino kalcio druska	2850 anti-Xa TV

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119435	105539	1105539	užpildytas švirkštas	0,3 ml N6	ASPĮ	Receptinis	LT/L/25/3078/001	Netiekiama	-	2026-07-01	No	-	-

Stadijos

Data	Stadija
2025-12-12	Registruotas